Mt2A - metallothionein 2A Gene
Also Known as Mt2
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 689415
Summary
Enables cadmium ion binding activity and zinc ion binding activity. Involved in astrocyte activation. Predicted to be located in cytoplasm and nucleus. Biomarker of Alzheimer's disease; kidney failure; median neuropathy; retinitis pigmentosa; and transient cerebral ischemia. Human ortholog(s) of this gene implicated in carotid stenosis and type 2 diabetes mellitus. Orthologous to several human genes including MT1E (metallothionein 1E); MT1F (metallothionein 1F); and MT1X (metallothionein 1X). [provided by Alliance of Genome Resources, Apr 2022]
Mt2A Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001137564.2 | NP_001131036.1 | metallothionein 2A |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
metallothionein 2A |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS08743 | MT2A Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-168969 | AA-BR-157 | 96.47% | Unkown | |
| HY-168970 | MT2A ligand 1 | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service